Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > No follow through

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jan 13, 2021 9:26am

158 Views

Post# 32283684

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:No follow through

And how long after the trial was the presentation?? You know nothing John Rose.

Redbaron2211 wrote: Bio they presented results on the hemophilia trials last May that's 8 moths ago. Next step is the clinic. Sure things might be slower with covid but no need to spread misinformation trying to give the impression this is a one trick pony. We all know your motives. I will stay positive, it has served me well. Cheers.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market